West announced as company of the year finalist for global generics and biosimilar awards 2022

Exton, pa. , oct. 6, 2022 /prnewswire/ -- west pharmaceutical services, inc. (nyse: wst), a global leader in innovative solutions for injectable drug administration, today announced it has been shortlisted for company of the year for 2022 global generics and biosimilar awards, which will be announced during cphi worldwide in frankfurt, germany on november 2, 2022. "west is honored to be shortlisted for the global generics and biosimilar 2022 company of the year award," said david maier, vice president & general manager at west pharmaceutical services.
WST Ratings Summary
WST Quant Ranking